Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized single-masked crossover study of Cosopt versus timolol on retinal perfusion and oxygen saturation in glaucoma
2005-005930-11Phase 4Active
- Sponsor
- Universitätsklinikum Erlangen Augenklinik
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dorzolamide and timolol in Glaucoma (2 arms), sponsored by Universitätsklinikum Erlangen Augenklinik. Primary endpoint: Protocol violation. Started Jun 2006; status: active.
02
Drugs
dorzolamidetimolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on 2005-005930-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005930-11.